//Media Centre

You can read about our performance, latest achievements and important announcements and activities throughout the year. Connect with us on social media to keep on top of our latest news and opinions.

Follow us on small-icon-vimeo Vimeo small-icon-twitter Twitter and small-icon-in LinkedIn.

Media Contacts

PRnews_361Our media team are available for accredited media enquiries only.

Media contact:
John Kelly
Chief Executive

Tel: +61 (0)2 9099 4750

Company Brochure

For an overview of our products and services, download the latest Company Brochure

OEM Self-Test Brochure

 

Download our OEM Self-Test brochure to find out about our user-centred self-test RDT platform, designed to mitigate common user-errors and enhance test performance.

 

OEM Services Brochure

 OEM_Brochure_Atomo_Diagnostics_2017

Download our OEM services brochure to find out more about our custom device manufacturing services.

 AtomoRapid™ HIV Brochure

For an overview of Atomo’s award-winning professional use HIV test, download the Product Brochure

Atomo HIV Self Test Brochure

For an overview of Atomo’s safe, convenient and accurate HIV self-test product, download the Product Brochure

Latest press releases

2409, 2018

PRESS RELEASE: Mylan Extends Commitment to Fight HIV/AIDS by Partnering with Atomo Diagnostics to Expand Access to HIV Self-Testing in Low- and Middle-Income Countries

HERTFORDSHIRE, England, PITTSBURGH and SYDNEY, September 24, 2018 – Global pharmaceutical company Mylan N.V.(NASDAQ: MYL) and medical device company Atomo Diagnostics today announced a strategic partnership to commercialize CE-Marked in vitro HIV rapid diagnostic tests for [...]

506, 2018

Atomo Diagnostics and Owen Mumford partner to introduce best-in-class HIV rapid testing in European markets

Sydney, Australia and Woodstock, England – 05 June 2018 | Atomo Diagnostics and Owen Mumford Ltd have today announced a strategic partnership for commercialisation of innovative HIV rapid tests in European markets Owen Mumford acquires [...]

2002, 2018

Joint Press Announcement: RPS Diagnostics partners with Atomo Diagnostics

RPS Diagnostics partners with Atomo Diagnostics to develop next generation FebriDx blood tests for antibiotic stewardship in the outpatient setting Sarasota, Florida and Sydney, Australia (February 20, 2018) – United States biotechnology company, RPS Diagnostics [...]

2301, 2018

Atomo Diagnostics and Access Bio partner to expand access to best-in-class HIV rapid testing in global markets

Sydney, Australia and Seoul, South Korea – 23 January 2018 | Atomo Diagnostics and Access Bio Inc. today announce a strategic partnership to leverage the respective strengths of both innovative rapid diagnostic test (RDT) companies [...]

612, 2017

PRESS RELEASE: Expert Review Panel for Diagnostics approves Atomo HIV Self Test for procurement by Unitaid and the Global Fund

Sydney, Australia, 7 December 2017 | Atomo Diagnostics, the world leader in integrated point-of-care rapid diagnostic devices, announced today that its Atomo HIV Self Test has been confirmed as eligible for procurement by organisations entitled [...]

1010, 2017

PRESS RELEASE: CE Marking for world’s only integrated HIV Self-Test from Atomo Diagnostics gives access to safe, accurate and reliable self-testing

  SYDNEY, AUSTRALIA, October 10, 2017 – Atomo Diagnostics, a world leader in innovative point-of-care, rapid diagnostic devices, announced today that its Atomo HIV Self Test has been granted CE Marking by a European Union [...]